Founded | 1971 |
---|---|
Type | Non-government organization |
Focus |
|
Location |
|
Area served | Field offices in 32 nations Currently operating in 70 nations |
Revenue | $790,200,000+ (2019) |
Employees | 4,000 employees |
Website | www |
Formerly called | Family Health International, International Fertility Research Program |
FHI 360 (formerly Family Health International) is a nonprofit human development organization based in North Carolina. FHI 360 operates in more than 70 countries and all U.S. states and territories. Established in 1971, the organization manages projects relating to family planning and reproductive health. In 1986 the organization began a worldwide response to HIV/AIDS. [1] [2] [3] FHI 360's research and programs also address malaria, tuberculosis, and other infectious and chronic diseases and international agencies, governments, foundations, research institutions, and individual donors. [4] [5]
Other major sponsors of HIV/AIDS programs, as well as other health and development areas, include the United Kingdom's Department for International Development (DFID), the Bill and Melinda Gates Foundation and the Global Fund to Fight AIDS, Tuberculosis and Malaria. [6] [7] Other governments, private foundations, and the private sector have partnered with FHI 360 to overcome health and development challenges. [8] [9]
In 2010, Family Health International rebranded itself with a new tagline, "The science of improving lives". The name was simplified to FHI, reflecting a broadened scope that encompasses health and development as well as service to families, communities, and nations. [10]
In 2011, Family Health International and Academy for Educational Development came together to create FHI 360. Staff includes experts in health, education, nutrition, environment, economic development, civil society, gender equality, youth, research and technology. FHI 360 serves more than 70 countries and all U.S. states and territories. [11]
FHI 360 contributed to a clinical trial called CAPRISA 004, which provided an important breakthrough in the fight against HIV and genital herpes with a vaginal gel that significantly reduces a woman's risk of infection. [12] [13] [14] [15]
Family Health International's President for Public Health Programs, Peter Lamptey, was named a member of the CSIS Commission on Smart Global Health Policy in 2009. [16] [17] The Commission brings together 26 prominent leaders from the private sector, the United States Congress, academia, media, and the security, foreign policy, and global health communities to set goals and priorities for US global health efforts. [18]
The Commission released its final report titled "A Healthier, Safer, and More Prosperous World" in March 2010. [19]
Microbicides for sexually transmitted infections are pharmacologic agents and chemical substances that are capable of killing or destroying certain microorganisms that commonly cause sexually transmitted infection.
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is the global health funding by the United States to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. The U.S. allocation of over $110 billion marks the largest investment by any country has ever made towards combating a single disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023, PEPFAR has saved over 25 million lives, primarily in sub-Saharan Africa.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing and partnership organization that aims to "attract, leverage and invest additional resources to end the epidemics of HIV/AIDS, tuberculosis and malaria to support attainment of the Sustainable Development Goals established by the United Nations". This multistakeholder international organization maintains its secretariat in Geneva, Switzerland. The organization began operations in January 2002. Microsoft founder Bill Gates was one of the first donors to provide seed money for the partnership. From January 2006 it has benefited from certain US Privileges, Exemptions, and Immunities under executive order 13395, which conferred International Organizations Immunities Act status on it.
Diseases of poverty, also known as poverty-related diseases, are diseases that are more prevalent in low-income populations. They include infectious diseases, as well as diseases related to malnutrition and poor health behaviour. Poverty is one of the major social determinants of health. The World Health Report (2002) states that diseases of poverty account for 45% of the disease burden in the countries with high poverty rate which are preventable or treatable with existing interventions. Diseases of poverty are often co-morbid and ubiquitous with malnutrition. Poverty increases the chances of having these diseases as the deprivation of shelter, safe drinking water, nutritious food, sanitation, and access to health services contributes towards poor health behaviour. At the same time, these diseases act as a barrier for economic growth to affected people and families caring for them which in turn results into increased poverty in the community. These diseases produced in part by poverty are in contrast to diseases of affluence, which are diseases thought to be a result of increasing wealth in a society.
Health in Vietnam encompasses general and specific concerns to the region, its history, and various socioeconomic status, such as dealing with malnutrition, effects of Agent Orange as well as psychological issues from the Vietnam War, tropical diseases, and other issues such as underdeveloped healthcare systems or inadequate ratio of healthcare or social workers to patients.
The anti-prostitution pledge is an organization-wide policy opposing prostitution and sex-trafficking that the federal government of the United States requires certain non-governmental organizations (NGOs) to adopt in order for them to receive federal anti-HIV/AIDS or anti-trafficking funds. This requirement has been in place since 2003.
Cases of HIV/AIDS in Peru are considered to have reached the level of a concentrated epidemic.
The Millennium Foundation for Innovative Finance for Health is an independent, non-profit Swiss organization, established in November 2008 in order to create new ways to finance health systems in low- and middle-income countries. Based in Geneva, Switzerland, the Millennium Foundation aims to ensure that international commitments on improving health care are met through the development of innovative financing projects. Its first such project – called MassiveGood – was launched on 4 March, and will give travelers the possibility to add a $2, £2 or €2 micro-contribution to the purchase of a travel reservation, with all proceeds going to the fight against HIV/AIDS, malaria and tuberculosis.
Global Health Initiatives (GHIs) are humanitarian initiatives that raise and disburse additional funds for infectious diseases – such as AIDS, tuberculosis, and malaria – for immunizations and for strengthening health systems in developing countries. GHIs classify a type of global initiative, which is defined as an organized effort integrating the involvement of organizations, individuals, and stakeholders around the world to address a global issue.
CAPRISA 004 was a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's risk of contracting HIV. The gel used in the study contained a microbicide.
Zeda Fran Rosenberg is an American microbiologist and epidemiologist, active in HIV biology and prevention. She is the chief executive officer of the International Partnership for Microbicides (IPM). IPM was founded by Rosenberg in 2002 and is a nonprofit organization dedicated to developing microbicides and other innovative HIV prevention products and making them available for women in developing countries.
CONRAD is a non-profit scientific research organization that works to improve global and reproductive health, particularly in women in developing countries. CONRAD was established in 1986 under a cooperative agreement between Eastern Virginia Medical School (EVMS) and the United States Agency for International Development (USAID). CONRAD’s products are developed primarily for women in low-resource settings, in that they are designed to be safe, affordable and user-friendly. CONRAD is led by Scientific and Executive Director Gustavo F. Doncel, M.D., Ph.D. Primary funding for CONRAD comes from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID), with additional funding from The Bill & Melinda Gates Foundation and the National Institutes of Health (NIH).
Michel Kazatchkine is a French physician, diplomat and advocate who is best known for his work in international AIDS treatment issues. From February 2007 to March 2012 he was director of The Global Fund to Fight AIDS, Tuberculosis and Malaria. On July 20, 2012, UN Secretary-General Ban Ki-moon appointed him as his United Nations Special Envoy for HIV/AIDS in Eastern Europe and Central Asia.
The quality of health in Rwanda has historically been very low, both before and immediately after the 1994 genocide. In 1998, more than one in five children died before their fifth birthday, often from malaria. But in recent years Rwanda has seen improvement on a number of key health indicators. Between 2005 and 2013, life expectancy increased from 55.2 to 64.0, under-5 mortality decreased from 106.4 to 52.0 per 1,000 live births, and incidence of tuberculosis has dropped from 101 to 69 per 100,000 people. The country's progress in healthcare has been cited by the international media and charities. The Atlantic devoted an article to "Rwanda's Historic Health Recovery". Partners In Health described the health gains "among the most dramatic the world has seen in the last 50 years".
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Dr. Debrework Zewdie, former director of the World Bank Global AIDS Program and Deputy Executive Director and COO of the Global Fund, is an Ethiopian national who has led strategy, policy implementation, and management of development programs at country, regional, and global levels for international bodies such as the World Bank and The Global Fund to Fight AIDS, Tuberculosis and Malaria. As an immunologist, she conceptualized and managed the groundbreaking US$1 billion Multi-country HIV/AIDS Program that changed the AIDS funding landscape and pioneered the large-scale multi-sectorial response with direct financing to civil society and the private sector. Dr. Zewdie led the articulation of the World Bank's first global strategy on HIV/AIDS and the Global HIV/AIDS Program of Action. As a founding UNAIDS Global Coordinator, she has been instrumental in making the unique cooperative structure of the UNAIDS family a working reality, fostering strong inter-agency partnerships. She is an advocate for women's health and was a founding vice president and member of the Society for Women and AIDS in Africa (SWAA). She established institutional rigor at the Global Fund and led its wide-ranging internal reform which culminated in the ongoing corporate transformation program. Dr. Zewdie has a Ph.D. in clinical immunology from the University of London, a postdoctoral fellowship at SYVA Company, and was a Senior MacArthur Fellow at the Harvard Center for Population and Development Studies. Dr. Zewdie was a Richard L. and Ronay A. Menschel Senior Leadership Fellow at the Harvard T.H. Chan School of Public Health in 2015. During her Fellowship at the Harvard Chan School, she also participated as a speaker on Voices in Leadership, an original webcast series, in a discussion titled, "Leadership in Getting AIDS on the World Bank Agenda", moderated by Dr. Barry Bloom.
Robert Michael Hecht is an American global health policy and financing expert. Hecht is currently Founder and President of Pharos Global Health Advisors. He has previously held positions with the World Bank, UNAIDS, the International AIDS Vaccine Initiative, and Results for Development Institute. He serves as a lecturer at Yale University’s Jackson Institute for Global Affairs and is a clinical professor at the Yale School of Public Health. He has published on a range of topics in global health and development, with a special focus on the economics, financing, and policies for infectious diseases, nutrition, and broader health system reform. He has been an advisor to the President's Emergency Plan for AIDS Relief (PEPFAR), the World Health Organization, and UNITAID. Hecht holds a BA from Yale and a PhD from Cambridge University.
College of Medicine, University of Lagos (CMUL) also known as Medilag is the medical school affiliated with the University of Lagos. It is located in Idi-Araba, Lagos beside its sister institution, the Lagos University Teaching Hospital. The college has a total staff of 1,850 in 32 departments.
The United States is the largest donor of multilateral global health funds. According to the Office of Management and Budget, the U.S. government contributes <1% of the federal budget for foreign aid including global health activities. In 2023, the U.S. contributed 12.9 billion USD towards global health activities across several health verticals including HIV, Tuberculosis, Malaria and COVID-19.
{{cite news}}
: |author=
has generic name (help){{cite journal}}
: CS1 maint: numeric names: authors list (link)